CSPC Pharmaceutical Group Limited
CSPC Pharmaceutical Group Limited (HKSE: 1093) is trading at HK$9.39, about ₹115 at today's HKD/INR rate, as of 28 Sep 2026, 4:08 AM ET, up 0.64% today. Indian residents can buy CSPC Pharmaceutical from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
HK$9.29
Today's high
HK$9.55
52 week low
HK$6.53
52 week high
HK$10.96
1093 opened at HK$9.40, closed previously at HK$9.33, and has traded between HK$6.53 and HK$10.96 over the past 52 weeks.
About
CSPC Pharmaceutical Group Limited, primarily an investment holding entity, is dedicated to the development, production, and distribution of pharmaceutical goods. Its operations span the globe, with a significant presence in the People's Republic of China, across Asia, in the Americas, and throughout Europe. The company structures its business activities into three main divisions: Finished Drugs, Bulk Products, and Functional Food and Other ventures. The company's extensive portfolio of finished drugs encompasses treatments for a wide range of conditions. Key offerings include NBP (available as soft capsules and injections) for acute ischemic stroke, and Oulaining (capsules and injections) addressing mild to moderate memory and cognitive impairments. For neurological disorders, Enxi targets adult idiopathic Parkinson's disease. In oncology, Duomeisu treats lymphoma, multiple myeloma, ovarian and breast cancers, alongside other malignant tumors, while Jinyouli aids in preventing chemotherapy-induced leucopenia and infections, and Keaili is prescribed for breast cancer. Further therapeutic areas covered by CSPC include various infections, with products such as Shuluoke, Nuomoling, Weihong, and Xinweihong. Cardiovascular health is addressed by Xuanning for hypertension and Encun to avert atherosclerotic thrombosis events. Qixiao provides relief for upper respiratory tract infections, and diabetes management is supported by Linmeixin and Shuanglexin. Bone health solutions include Gubang and Gubangjia for postmenopausal osteoporosis. Additionally, Gaoshunsong offers relief for a broad spectrum of inflammatory and pain-related conditions, including arthritis, osteoarthritis, ankylosing spondylitis, frozen shoulder, bursitis, tenosynovitis, acute gout, dysmenorrhea, toothache, postoperative pain, lower back pain, sprains, strains, and other soft tissue injuries. Other notable products include Debixin for various types of ulcers and Qimaite for acute and chronic pain management. Beyond finished pharmaceuticals, CSPC also supplies active pharmaceutical ingredients (APIs) like antibiotics, vitamin C, and caffeine. The company further diversifies into functional foods, glucose products, and provides healthcare services. Originally established in 1992, the company initially operated under the name China Pharmaceutical Group Limited before adopting its current designation, CSPC Pharmaceutical Group Limited, in March 2013. Its primary corporate office is situated in Shijiazhuang, within the People's Republic of China.
Key statistics
Avg. volume
102.30M
Market cap
HK$107.10B
P/E Ratio
12.36
Price-to-sales ratio
2.97
Enterprise value
CN¥82.25B
Free cash flow yield
13.33%
Debt-to-equity ratio
0.02
Return on equity
20.68%
ROIC
17.35%
Beta
0.76
Dividend yield
3.09%
Last dividend
HK$0.29
Financial overview
Revenue
CN¥25.33B
Earnings per share
CN¥0.33
Free cash flow
CN¥3.99B
Net profit margin
23.73%
Gross margin
71.86%
EBITDA
CN¥5.24B
Revenue growth
-14.24%
Similar securities
This is not an investment recommendation
How to buy CSPC Pharmaceutical from India
Indian residents can buy CSPC Pharmaceutical shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to HKD.
Search for CSPC Pharmaceutical and place an order
Find CSPC Pharmaceutical by name or by its ticker, 1093, and choose an order type. Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share. CSPC Pharmaceutical trades 7:00 am – 1:30 pm IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your CSPC Pharmaceutical position in HKD and INR, and use Paasa's capital-gains and dividend statements when you file your Indian return.
Read the full guide: how to invest in CSPC Pharmaceutical from India
Trading and taxes when buying CSPC Pharmaceutical from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm HKT
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- Slab rateDividends are taxed at your slab rate in India. CSPC Pharmaceutical’s current yield is 3.09%.Dividend tax explained
Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
FAQs
Can Indian residents buy CSPC Pharmaceutical stock?
Yes. CSPC Pharmaceutical (1093) has been listed on the Hong Kong Stock Exchange since 1994, in the Drug Manufacturers - General industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to HKD. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one CSPC Pharmaceutical share cost in rupees?
One CSPC Pharmaceutical share is HK$9.39 — about ₹115 at an HKD/INR rate of 12.24 on 27 Sep 2026. Both the CSPC Pharmaceutical price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying CSPC Pharmaceutical from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
What is the minimum I can buy of CSPC Pharmaceutical?
Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share.
How are gains on CSPC Pharmaceutical shares taxed in India?
Hong Kong generally does not levy capital gains tax on non-resident individual investors for HKEX-listed stocks, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the HKD/INR rate on the purchase and the sale date, so the rupee move counts alongside the CSPC Pharmaceutical price. Paasa issues a capital-gains statement for your return.
Does CSPC Pharmaceutical pay a dividend, and how is it taxed in India?
Yes. CSPC Pharmaceutical pays a dividend and the current yield is 3.09%; the last declared dividend was HK$0.29 per share, about ₹3.55. Dividends are taxed at your slab rate in India. Paasa's dividend report lists the gross dividend and any tax withheld for each payment.
When can I trade CSPC Pharmaceutical from India?
The Hong Kong Stock Exchange trades 7:00 am – 1:30 pm IST in Indian time. It also halts for lunch, 9:30 am – 10:30 am IST. Orders can only execute during that window.
Is CSPC Pharmaceutical a Hong Kong SAR China company, and does that change how it is taxed?
CSPC Pharmaceutical trades on the Hong Kong Stock Exchange in HKD, but the company is domiciled in China. CSPC Pharmaceutical trades as an ordinary share listed directly in Hong Kong, not a depositary receipt. Your India-side capital-gains treatment is the same either way.
Do I have to declare CSPC Pharmaceutical shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your CSPC Pharmaceutical holding, its cost and its closing value.
How do I sell CSPC Pharmaceutical and bring the money back to India?
You sell during market hours (7:00 am – 1:30 pm IST) and the proceeds settle in HKD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.